Jiangsu, China

Chengqian Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chengqian Wang. Retrieved from https://idiyas.com/inventor/chengqian-wang-crvoye3p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chengqian Wang

Introduction: Chengqian Wang, based in Jiangsu, China, is a proficient inventor with a focus on developing innovative solutions in the pharmaceutical field. His notable contribution includes a patent related to the treatment of a serious health condition, showcasing his commitment to advancing medical science.

Latest Patents: Chengqian Wang holds a patent for a quinoline derivative intended for the treatment of nasopharyngeal carcinoma. This invention not only provides a new approach to addressing this type of cancer but also outlines its application in formulating a pharmaceutical composition aimed at tumor treatment.

Career Highlights: Chengqian Wang works at Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His position within this esteemed organization allows him to engage in groundbreaking research and development, contributing to the advancement of healthcare solutions.

Collaborations: Throughout his career, Chengqian has collaborated with talented coworkers, including Shanchun Wang and Jun Shen. Working alongside such professionals enhances his innovative capacity and fosters an environment conducive to significant advancements in pharmaceutical research.

Conclusion: Chengqian Wang exemplifies the role of inventors in the ever-evolving landscape of medical innovation. His patent for a quinoline derivative reflects both his dedication to improving treatment options and the potential impact of collaborative efforts in advancing medical research. As the company he works for continues to thrive, it is likely that Chengqian will remain a key figure in the pursuit of pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…